BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 23904397)

  • 1. Impact of age on survival predictability of bone turnover markers in hemodialysis patients.
    Lertdumrongluk P; Lau WL; Park J; Rhee CM; Kovesdy CP; Kalantar-Zadeh K
    Nephrol Dial Transplant; 2013 Oct; 28(10):2535-45. PubMed ID: 23904397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative mortality-predictability using alkaline phosphatase and parathyroid hormone in patients on peritoneal dialysis and hemodialysis.
    Rhee CM; Molnar MZ; Lau WL; Ravel V; Kovesdy CP; Mehrotra R; Kalantar-Zadeh K
    Perit Dial Int; 2014; 34(7):732-48. PubMed ID: 24385335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bone biomarkers in haemodialysis patients: bone alkaline phosphatase or ß-Crosslaps?].
    Jean G; Souberbielle JC; Granjon S; Lorriaux C; Hurot JM; Mayor B; Deleaval P; Chazot C
    Nephrol Ther; 2013 Jun; 9(3):154-9. PubMed ID: 23545236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ratio of paricalcitol dosage to serum parathyroid hormone level and survival in maintenance hemodialysis patients.
    Shinaberger CS; Kopple JD; Kovesdy CP; McAllister CJ; van Wyck D; Greenland S; Kalantar-Zadeh K
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1769-76. PubMed ID: 18701614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathormone and bone-specific alkaline phosphatase for the follow-up of bone turnover in hemodialysis patients: is it so simple?
    Delanaye P; Dubois BE; Jouret F; Krzesinski JM; Moranne O; Cavalier E
    Clin Chim Acta; 2013 Feb; 417():35-8. PubMed ID: 23262367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study.
    Fernández-Martín JL; Martínez-Camblor P; Dionisi MP; Floege J; Ketteler M; London G; Locatelli F; Gorriz JL; Rutkowski B; Ferreira A; Bos WJ; Covic A; Rodríguez-García M; Sánchez JE; Rodríguez-Puyol D; Cannata-Andia JB;
    Nephrol Dial Transplant; 2015 Sep; 30(9):1542-51. PubMed ID: 25920921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Parameters of Mineral Bone Disorder with Mortality in Patients on Hemodialysis according to Level of Residual Kidney Function.
    Wang M; Obi Y; Streja E; Rhee CM; Lau WL; Chen J; Hao C; Hamano T; Kovesdy CP; Kalantar-Zadeh K
    Clin J Am Soc Nephrol; 2017 Jul; 12(7):1118-1127. PubMed ID: 28487345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlates of parathyroid hormone concentration in hemodialysis patients.
    Li J; Molnar MZ; Zaritsky JJ; Sim JJ; Streja E; Kovesdy CP; Salusky I; Kalantar-Zadeh K
    Nephrol Dial Transplant; 2013 Jun; 28(6):1516-25. PubMed ID: 23348879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory effect of parathyroid hormone on sRANKL-osteoprotegerin in hemodialysis patients with renal bone disease.
    Doumouchtsis K; Perrea D; Doumouchtsis S; Tziamalis M; Poulakou M; Vlachos I; Kostakis A
    Ther Apher Dial; 2009 Feb; 13(1):49-55. PubMed ID: 19379170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone-specific alkaline phosphatase concentrations are less variable than those of parathyroid hormone in stable hemodialysis patients.
    Sardiwal S; Gardham C; Coleman AE; Stevens PE; Delaney MP; Lamb EJ
    Kidney Int; 2012 Jul; 82(1):100-5. PubMed ID: 22456600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect Modifying Role of Serum Calcium on Mortality-Predictability of PTH and Alkaline Phosphatase in Hemodialysis Patients: An Investigation Using Data from the Taiwan Renal Registry Data System from 2005 to 2012.
    Lin YC; Lin YC; Hsu CY; Kao CC; Chang FC; Chen TW; Chen HH; Hsu CC; Wu MS;
    PLoS One; 2015; 10(6):e0129737. PubMed ID: 26107510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome predictability of serum alkaline phosphatase in men with pre-dialysis CKD.
    Kovesdy CP; Ureche V; Lu JL; Kalantar-Zadeh K
    Nephrol Dial Transplant; 2010 Sep; 25(9):3003-11. PubMed ID: 20299338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Novel Bone Alkaline Phosphatase Isoform B1x Is Associated with Improved 5-Year Survival in Chronic Kidney Disease.
    Haarhaus M; Fernström A; Qureshi AR; Magnusson P
    Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of relatively low serum parathyroid hormone with malnutrition-inflammation complex and survival in maintenance hemodialysis patients.
    Dukkipati R; Kovesdy CP; Colman S; Budoff MJ; Nissenson AR; Sprague SM; Kopple JD; Kalantar-Zadeh K
    J Ren Nutr; 2010 Jul; 20(4):243-54. PubMed ID: 20199875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis.
    Qi Q; Monier-Faugere MC; Geng Z; Malluche HH
    Am J Kidney Dis; 1995 Oct; 26(4):622-31. PubMed ID: 7573017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of vitamin K2 in hemodialysis patients with low serum parathyroid hormone levels.
    Nakashima A; Yorioka N; Doi S; Masaki T; Ito T; Harada S
    Bone; 2004 Mar; 34(3):579-83. PubMed ID: 15003806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of 1-84 PTH measurement in relation to bone alkaline phosphatase and bone Gla protein in hemodialysis patients.
    Miwa N; Nitta K; Kimata N; Watanabe Y; Suzuki K; Kawashima A; Haga M; Watanabe R; Aoki T; Akiba T; Nihei H
    Nephron Clin Pract; 2003; 94(2):c29-32. PubMed ID: 12845234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High alkaline phosphatase and low intact parathyroid hormone associate with worse clinical outcome in peritoneal dialysis patients.
    Chen Z; Zhang X; Han F; Xie X; Hua Z; Huang X; Lindholm B; Haarhaus M; Stenvinkel P; Qureshi AR; Chen J
    Perit Dial Int; 2021 Mar; 41(2):236-243. PubMed ID: 32363998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased active PTH(1-84) fraction as a predictor of poor mortality in male hemodialysis patients.
    Inaba M; Okuno S; Imanishi Y; Ishimura E; Yamakawa T; Shoji S
    Osteoporos Int; 2013 Nov; 24(11):2863-70. PubMed ID: 24030285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoalbuminemia differently affects the serum bone turnover markers in hemodialysis patients.
    Zheng CM; Wu CC; Lu CL; Hou YC; Wu MS; Hsu YH; Chen R; Chang TJ; Shyu JF; Lin YF; Lu KC
    Int J Med Sci; 2019; 16(12):1583-1592. PubMed ID: 31839746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.